Description:

PRCT is the ticker symbol for Precigen Inc., a biotechnology company listed on the New York Stock Exchange. Precigen focuses on advancing therapies that utilize gene and cell technologies to treat various diseases, including cancer and rare genetic disorders. The company's innovative approach aims to harness the power of precision medicine to develop transformative treatments for patients in need. Through its proprietary technology platforms, Precigen seeks to accelerate the development of its pipeline and deliver promising solutions to unmet medical needs.

Data:

Yields: